Table 4 Positive rate and timing of anti-Eno and anti-Fba1 antibodies in non-neutropenic and neutropenic patients with candidemia [ n (%)]
Population (No. of subjects) | Anti-Eno | Anti-Fba1 | ||||
|---|---|---|---|---|---|---|
Ab*(+) prior to BC(+) | BC**(+) prior to Ab(+) | Total | Ab(+) prior to BC(+) | BC(+) prior to Ab(+) | Total | |
Non-neutropenia (90) | 38 (42.2) | 31 (34.4) | 69 (76.7) | 46 (51.1) | 37 (41.1) | 83 (92.2) |
Neutropenia# (11) | 3 (27.3) | 1 (9.1) | 4 (36.4)a | 4 (36.4) | 1 (9.1) | 5 (45.5)b |
Total (101) | 41 (40.6) | 32 (31.7) | 73 (72.3) | 50 (49.5) | 38 (37.6) | 88 (87.1) |